Roche’s Virtual Neurology Investor Event
Roche has hosted a virtual event on Thursday, 31 October 2024
| Agenda | |
|---|---|
| Introduction | Bruno Eschli, Head of Investor Relations |
| Roche in Alzheimer’s Disease | Azad Bonni, SVP and Global Head of Neuroscience & Rare Diseases at pRED |
| Trontinemab data at CTAD 2024 | Luka Kulic, Therapeutic Area Leader Dementias and Expert Medical Director in Neuroscience & Rare Diseases, at pRED |
| Elecsys Biomarker data at CTAD 2024 | Margherita Carboni, Indication Lead, Neurology and Clinical Development Lead in Neurology, Endocrinology and OBGYN at Roche Diagnostics |
| Q&A |